Single award · contract
Advance Universal Influenza Vaccine - Flu Mosaic Version 2 (FLUMOSV2)
Award ID: 75N91021F00004
FY2021 · complete year · data as of 2026-07-12
A single federal award, with both ends of the trail linked.
$141.7M
Total award value
Award 75N91021F00004 is a contract from the Department of Health and Human Services to Leidos Biomedical Research Inc, $141.7M obligated, FY2021 to FY2031, for Advance Universal Influenza Vaccine - Flu Mosaic Version 2 (FLUMOSV2). The work is performed in Maryland. It is classified as NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)) and PSC AN12 (Health R&D Services; Health Care Services; Applied Research). Source
Award details
Award typeContract
PIID75N91021F00004
Action date2021
Period119 mo
Awarding agencyDepartment of Health and Human Services →
RecipientLeidos Biomedical Research Inc →
Place of performanceMaryland →
CategoryNAICS 541715PSC AN12
Competed?Not recordedSource
Total (exact)$141,656,003
More awards to Leidos Biomedical Research Inc
awarded 2008$4.8B
awarded 2020$1.8B
awarded 2025$826M
awarded 2019$432.4M
awarded 2024$398.9M
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.